ABSTRACT. Sepsis is a major cause of morbidity and mortality in critically ill patients. The sepsis syndrome results from a dysregulated inflammatory response to infection that leads to multiple-organ failure, but the underlying mechanisms remain poorly understood. More and more reports show that microRNAs (miRNAs) play an important role in sepsis. In the progression of this syndrome, cells change their behavior in response to cytokines stimulated by sepsis, such as interleukin-10 (IL-10). IL-10 can activate JAK2-STAT3 in the cells to protect them from damage. miR-29a is a potential miRNA directly targeting STAT3. In this study, we investigate the role of miR-29a in targeting STAT3 during sepsis. When cells were treated with IL-10, STAT3 was activated in monocytes, as determined using western blotting. It was verified that STAT3 was a new target gene of miR-29a. miR-29a could inhibit IL-10-induced cytokine release by targeting JAK-STAT3 in monocytes. In conclusion, this study demonstrates for the first time that miR-29a inhibits STAT3 in human monocytes during sepsis.
INTRODUCTION
Sepsis is a major cause of morbidity and mortality in critically ill patients. The sepsis syndrome results from a dysregulated inflammatory response to infection that leads to multipleorgan failure (López-Abarrategui et al., 2013; Liesenfeld et al., 2014) . A common and severe complication of sepsis is renal insufficiency. Impaired renal function accentuates the pathogenesis of sepsis through the loss of metabolic, fluid, and electrolyte homeostasis (Hotchkiss et al., 2013; Florescu and Kalil, 2014) , and the development of kidney dysfunction doubles the risk for mortality in septic patients (Boomer et al., 2014) . Bacterial sepsis and acute endotoxemia induce a number of defects, but the underlying mechanisms remain poorly understood.
MicroRNAs (miRNAs) are a class of RNA molecules that control posttranscriptional gene expression primarily by complementary base pairing with specific "seed" sequences in the 3' -untranslated region (3'-UTR) of their target mRNAs (Vandooren et al., 2013) . The expression levels of specific miRNAs can have diagnostic value for various forms of malignancy (Ivády et al., 2011; Sinkovics, 2012) and may also provide insight into disease pathogenesis (Hennessy et al., 2010; Reid et al., 2011) . Recently, a number of studies have looked at a limited set of miRNAs and have shown that their expression is altered in the context of inflammation or sepsis, both in vitro and in vivo Wang et al., 2013; Wang et al., 2014) . Reports have shown that miR-187, miR-146a, etc., play important roles in sepsis.
In the current study, we examined the role of miR-29a in the regulation of interleukin-10 (IL-10)-induced STAT3 in the context of inflammation and determined the molecular basis for lipopolysaccharide (LPS) hyporesponsiveness and STAT3 expression in the presence of IL-10 in human monocytes. This study demonstrates, for the first time, that miR-29a inhibits STAT3 expression and plays important roles in human monocytes during sepsis.
MATERIAL AND METHODS

Cell culture
THP-1 cells were purchased from the ATCC (Manassas, VA, USA). The cells were maintained in Dulbecco's modified Eagle's medium (Gibco, USA) supplemented with 10% fetal bovine serum in a humidified incubator at 37°C and 5% CO 2 . Monocytes were isolated from the blood of mice in a mouse model of sepsis or from healthy mice.
ELISA
Cells were grown overnight on 12-well plates (4 x 10 5 cells/well), supernatants were collected, and cytokines were determined by a sandwich enzyme-linked immunosorbent assay (ELISA) according to the manufacturer directions (R&D Systems). Absorption was measured at 450 nm on a Versa Max microplate reader using SoftMaxPro software 5.2 (Molecular Devices, Sunnyvale, CA).
Generation of luciferase reporter constructs
An approximately 2-kb upstream regulatory region from the major transcription start site of the STAT3 gene was amplified by PCR from human genomic DNA and cloned into pGL4-Basic (Promega, WI, USA) by using NheI and HindIII, generating the STAT3-luciferase reporter plasmid. A series of different 5'-truncated fragments were created by PCR amplification from the 2-kb-reporter plasmid and inserted into the pGL4-Basic vector as described above. Site-directed mutagenesis was performed with a MutanBEST kit (Takara, Japan), using the reporter plasmid as a template. The site-specific mutations were confirmed by sequencing.
Lentivirus vectors and lentivirus production
The pLKO.1-puro-miR-29a vector was created by annealing of sense (5'-ccggcttccagtcga ggatgtttacactcgagtgtaaacatcctcgactggaagtttttg-3') and antisense (5'-aattcaaaaacttccagtcgaggatgt ttacactcgagtgtaaacatcctcgactggaag-3') oligonucleotides to each other and subsequent cloning of the resulting double-stranded DNA molecule into the AgeI/EcoRI sites of the pLKO.1-puro vector (kindly provided by Sheila Stewart). The empty pLKO.1-puro vector was used as a control. Lentiviruses were produced by transfecting packaging cells (human embryonic kidney 293T cells) with a 3-plasmid system.
Transfection and dual-luciferase assay
Cells were plated on 24-well plates 24 h before transfection. Transient transfection was carried out in Opti-MEM medium by using Lipofectamine-2000 according to the manufacturer protocol (Invitrogen, CA, USA). About 6 h later, the medium was changed, and the cells incubated at 37°C for the indicated time. Cells were washed once with phosphate-buffered saline (PBS), and luciferase assays were performed using a dual-luciferase assay system (Promega) according to the supplier protocol. Readings were taken with a Lumat LB 9507 instrument (Berthold Technologies, Germany).
RNA isolation and real-time RT-PCR
Total RNA was isolated from the cells by using Trizol reagent (Invitrogen) following the manufacturer instructions. Briefly, the cells were lysed in Trizol and then mixed with chloroform. The lysate was centrifuged to separate RNA, DNA, and protein, and total RNA was recovered, precipitated with isopropanol, and washed in 75% ethanol to remove impurities before being dissolved in water. After that, 2 μg of RNA was taken and treated with DNase to remove contaminating DNA prior to reverse transcription (RT) to cDNA by using a SYBR ® PCR kit (Takara). To measure mRNA expression, real-time RT-PCR was performed using a sequence detector (ABIPrism, Applied Biosystems, USA). The relative expression levels were calculated by comparing Ct values of the samples with those of the reference, and all data were normalized to the internal control, glyceraldehyde-3-phosphate dehydrogenase.
Western blotting
The cells were scraped from the dishes, cellular protein extracts prepared by homogenization in an ice-cold lysis buffer, their lysates obtained by centrifugation at 12,000 g for 20 min, and the total protein concentration determined using the Lowry method. Equal amounts of protein, separated by SDS-PAGE, were electrophoretically transferred to a polyvinylidene difluoride membrane at 320 mA for 2 h at a low temperature, and the membrane was blocked with 5% fatfree milk with 0.05% Tween 20 in PBS (PBST). Subsequently, the membrane was probed with the primary antibodies. The blots were washed in PBST and then incubated in anti-mouse IgG or antirabbit IgG secondary antibody for about 3 h at room temperature. The blots were washed in PBST (3X, 10 min each), and the proteins were finally visualized using enhanced chemiluminescence based on the manufacturer instructions.
Statistical analysis
Each experiment was repeated at least three times, and Student t-tests were performed to determine the statistical significance for the assays of promoter activity, migration, fluorescenceactivated cell sorting, and colony formation. Data are reported as means ± standard errors.
RESULTS
Sepsis induces IL-10 expression in human monocytes
There are many inflammatory cytokines secreted during sepsis which play important roles in the progression of the disease, and IL-10 is one of them. To investigate whether IL-10 expression increases during sepsis, monocytes were isolated from humans with sepsis or from normal controls, and the ELISA results showed that the IL-10 level was increased in the monocytes from 10 patients with sepsis ( Figure 1A ). The expression of IL-10 was confirmed for THP-1 cells with LPS treatment by using ELISA ( Figure 1B) . . IL-10 expression in monocytes is increased during sepsis. A. Fresh monocytes were isolated from humans with sepsis, and supernatants were collected. IL-10 was analyzed by ELISA. B. IL-10 expression in THP-1 monocytes with LPS treatment was confirmed by ELISA. Cells were stimulated with LPS (20 nM), and the growth medium was collected for ELISA. **P < 0.01.
IL-10 induces inhibition of apoptosis in monocytes by STAT3
To determine the role of IL-10 in the regulation of cell apoptosis and proliferation, THP-1 cells were exposed to IL-10 with or without LPS. It was found that IL-10 promoted cell proliferation and protected cells from apoptosis (Figure 2A and B) . Cytokines such as IL-6 can activate the JAK-STAT3 signaling pathway, and we wanted to know whether IL-10 can stimulate STAT3 activation. Fresh monocytes and THP-1 cells were treated with IL-10, and the data from western blotting showed that the p-STAT3 level increased in a time-dependent manner ( Figure 2C ). 
STAT3 is a new target gene of miR-29a in monocytes
We then investigated the mechanisms by which miRNAs regulate STAT3 expression. Bioinformatic analysis showed that miR-29a may be a potential miRNA targeting STAT3 ( Figure  3A) . Thus, a luciferase reporter plasmid with the 3'-UTR of STAT3 was constructed. The luciferase activity of the wild-type luciferase reporter plasmid (STAT3-WT) was much lower in THP-1 cells than the activity of the luciferase reporter plasmid with the 3'-UTR of STAT3, and the luciferase activity of STAT3-Mut was rescued in cells ( Figure 3B ). We next examined whether miR-29a could regulate endogenous STAT3 expression in monocytes. Compared with the controls, endogenous STAT3 mRNA levels ( Figure 3C ) and protein levels ( Figure 3D ) were down-regulated when cells were transfected with miR-29a. These data indicate that STAT3 is a direct target gene of miR-29a. Figure 3 . miR-29a down-regulates STAT3 expression in THP-1 cells. A. The 3'-UTR of the STAT3 gene contains binding sites for miR-29a, according to bioinformatic analysis. B. miR-29a suppressed the expression of a luciferase reporter gene harboring the 3'-UTR of the STAT3 gene. Cells were transiently cotransfected with a negative control (mock) or miR-29a, together with the indicated luciferase constructs, and luciferase activity was analyzed 48 h later. Data are presented as the relative firefly luciferase activity normalized to the Renilla luciferase activity from the same construct. C. miR-29a restoration down-regulated STAT3 in THP-1 cells and fresh monocytes. Cells were transfected with miR-29a or miR-control for 48 h and then collected for western blot analysis. D. miR-29a restoration downregulated STAT3 in THP-1 cells and fresh monocytes. The data presented are means and standard deviations of the results from three independent experiments. **P < 0.01.
miR-29a inhibits IL-10-induced cell growth through down-regulation of STAT3
The data described above showed that miR-29a inhibited STAT3 mRNA and protein expression in monocytes. The remaining question was whether miR-29a inhibits cell proliferation by down-regulation of STAT3. To answer this question, the cells were treated with IL-10 and infected with LV-miR-29a, and the results of flow cytometry indicated that apoptosis increased in the cells with LV-miR-29a ( Figure 4A ). An MTT assay showed that miR-29a could inhibit cell proliferation ( Figure 4B ). . miR-29a promotes cell apoptosis and inhibits cell proliferation. A. Cells were transfected with miR-29a or miR-control, stimulated with IL-10 for 48 h, dyed with fluorescein isothiocyanate-annexin V, and then collected for flow cytometry. B. Cells were transfected with miR-29a or miR-control, stimulated with LPS for 48 and 96 h, and then subjected to MTT assay. **P < 0.01; *P < 0.05.
DISCUSSION
In this study, we investigated the molecular mechanism of STAT3 regulation by miR-29a-STAT3 in monocytes with sepsis. For the first time, we demonstrated that miR-29a inhibits the IL-10-STAT3 signaling pathway in monocytes.
Signal transducers and activators of transcription (STATs) are the principle signaling proteins of many cytokines and growth factors in mammals. STATs play a critical role in regulating immune cell homeostasis, differentiation, and cellular functions (Wu et al., 2013; Trilling et al., 2014) . There are seven STAT proteins (STAT1, STAT2, STAT3, STAT4, STAT6, and the STAT5a and STAT5b isoforms), each with established roles in immune cell functioning. The key regulation of STATs is mediated by phosphorylation, typically by Janus kinases (JAKs). STAT1 and -2 respond to interferons (IFNs), thereby promoting IFN-stimulated genes and antiviral immunity. STAT3 responds to factors including IL-6, IL-10, and vascular endothelial growth factor and is involved in T-helper cell 17 (Th17) and Treg cell development and tumorigenesis (Lin et al., 2013; Nieminen et al., 2013) . STAT4 and STAT6 control Th1 and Th2 cell differentiation in response to IL-12 and IL-4/13, respectively (Fontan and Melnick, 2013; Meisch et al., 2013; Singh et al., 2013) . Due to the large involvement of STATs in a variety of cell processes, it is critical that their activity be tightly regulated.
The IL-10 receptor, which is also constitutively expressed on these cells, activates the JAK/STAT pathway, inducing phosphorylation and dimerization of STAT3, which binds to the GAS of the promoter region of target genes (Pattison et al., 2013; Haque et al., 2014 ). In the current study, we showed that STAT3 is phosphorylated in response to IL-10, demonstrating that this pathway is activated in monocytes. Most importantly, we found that miR-29a regulates the function of monocytes by directly activating STAT3.
In summary, we examined the role of miR-29a in sepsis. STAT3 was predicted as the target gene of miR-29a by TargetScan and verified the predicted result. This study demonstrates that miR-29a inhibits sepsis by inhibition of STAT3 stimulated by IL-10 in human monocytes.
